The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124291882 12429188 2 F 2011 20160627 20160602 20160705 EXP US-ASTRAZENECA-2016SE57412 ASTRAZENECA 55.00 YR F Y 64.60000 KG 20160706 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124291882 12429188 1 PS BYETTA EXENATIDE 1 Subcutaneous TWO TIMES A DAY Y U 21773 SOLUTION FOR INJECTION IN PRE-FILLED PEN
124291882 12429188 2 SS BYDUREON EXENATIDE 1 Subcutaneous FA0150 0 2 MG /wk
124291882 12429188 3 C GLUCOPHAGE XR METFORMIN HYDROCHLORIDE 1 Oral 0 1000 MG Q12H
124291882 12429188 4 C HUMALOG INSULIN LISPRO 1 Subcutaneous 7-8 UNITS SUBCUTANEOUSLY BEFORE MEALS 0
124291882 12429188 5 C HUMALOG INSULIN LISPRO 1 Subcutaneous 10 UNITS SUBCUTANEOUSLY BEFORE MEAL 0
124291882 12429188 6 C LANTUS INSULIN GLARGINE 1 Subcutaneous 0 13 IU QD
124291882 12429188 7 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0 50 UG QD
124291882 12429188 8 C VERAPAMIL ER VERAPAMIL HYDROCHLORIDE 1 Oral 180.0MG UNKNOWN 0 180 MG
124291882 12429188 9 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 20.0MG UNKNOWN 0 20 MG
124291882 12429188 10 C IMITREX SUMATRIPTAN SUCCINATE 1 Subcutaneous 6.0MG AS REQUIRED 0 6 MG INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124291882 12429188 1 Diabetes mellitus
124291882 12429188 2 Diabetes mellitus
124291882 12429188 3 Diabetes mellitus
124291882 12429188 4 Diabetes mellitus
124291882 12429188 5 Diabetes mellitus
124291882 12429188 6 Diabetes mellitus
124291882 12429188 7 Thyroid disorder
124291882 12429188 8 Migraine prophylaxis
124291882 12429188 9 Blood cholesterol abnormal
124291882 12429188 10 Migraine

Outcome of event

Event ID CASEID OUTC COD
124291882 12429188 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124291882 12429188 Amnesia
124291882 12429188 Appetite disorder
124291882 12429188 Basal cell carcinoma
124291882 12429188 Blood glucose fluctuation
124291882 12429188 Drug dose omission
124291882 12429188 Glycosylated haemoglobin increased
124291882 12429188 Injection site extravasation
124291882 12429188 Injection site mass
124291882 12429188 Intentional product misuse
124291882 12429188 Malignant melanoma
124291882 12429188 Needle issue
124291882 12429188 Pernicious anaemia
124291882 12429188 Pustular psoriasis
124291882 12429188 Squamous cell carcinoma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124291882 12429188 1 2010 2013 0
124291882 12429188 2 20160205 0
124291882 12429188 5 20160524 20160524 0
124291882 12429188 7 2008 0
124291882 12429188 8 2009 0
124291882 12429188 9 2006 0